Solid Biosciences Inc (SLDB)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SLDB market cap is 315.48M. The company's latest EPS is USD -2.5017 and P/E is -3.29.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31.66M | -26.84M | -23.11M | -22.64M | -26.86M |
| Net Income | -30.07M | -24.63M | -20.98M | -20.34M | -24.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 13.62M | 8.09M | 0 |
| Operating Income | -119.32M | -88.41M | -72.25M | -106.45M | -104.25M |
| Net Income | -117.22M | -88.29M | -72.19M | -85.98M | -96.02M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 229.59M | 204.72M | 184.73M | 164.94M | 248.69M |
| Total Liabilities | 45.8M | 40.99M | 40.37M | 38.46M | 37.97M |
| Total Equity | 183.79M | 163.73M | 144.36M | 126.48M | 210.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 103.47M | 171.17M | 232.38M | 260.25M | 164.94M |
| Total Liabilities | 23.42M | 39.08M | 24.17M | 48.59M | 38.46M |
| Total Equity | 80.05M | 132.09M | 208.21M | 211.67M | 126.48M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -28M | -55.46M | -73.36M | -94.18M | -25.19M |
| Investing | 37.26M | -10.97M | -35.61M | 9.69M | -38.49M |
| Financing | N/A | 2.62M | 2.62M | 3.12M | 107.24M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -92.71M | -56.6M | -77.76M | -97.98M | -94.18M |
| Investing | 24.52M | 6.6M | -91.09M | 59.16M | 9.69M |
| Financing | 57.88M | 128.7M | 134.99M | 74.83M | 3.12M |
| Market Cap | 315.48M |
| Price to Earnings Ratio | -3.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.26 |
| Price to Book Ratio | 2.49 |
| Dividend Yield | - |
| Shares Outstanding | 38.38M |
| Average Volume (1 week) | 599.39k |
| Average Volume (1 Month) | 687k |
| 52 Week Change | 74.52% |
| 52 Week High | 15.05 |
| 52 Week Low | 1.81 |
| Spread (Intraday) | 0.45 (5.14%) |
| Company Name | Solid Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.solidbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
